Andrx Corporation
Records under this name other than patents Andrx Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,866,866 | Controlled release metformin compositions Term ended Term ended Apr 14, 2021 · USPTO record | Term ended | Term ended Apr 14, 2021 | USPTO record |
| US 6,790,459 | Methods for treating diabetes via administration of controlled release metformin Term ended Term ended Mar 17, 2021 · USPTO record | Term ended | Term ended Mar 17, 2021 | USPTO record |
| US 6,099,862 | Oral dosage form for the controlled release of a biguanide and sulfonylurea Term ended Term ended Aug 31, 2018 · USPTO record | Term ended | Term ended Aug 31, 2018 | USPTO record |
| US 6,720,003 | Serotonin reuptake inhibitor formulations Formerly held Lapsed on the fee record Ended Apr 13, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 13, 2016 | USPTO record |
| US 6,683,112 | Gabapentin prodrugs and formulations Formerly held Lapsed on the fee record Ended Jan 27, 2016 · USPTO record | Lapsed on the fee record | Ended Jan 27, 2016 | USPTO record |
| US 6,610,326 | Divalproex sodium tablets Lapsed on the fee record Ended Aug 26, 2015 · USPTO record | Lapsed on the fee record | Ended Aug 26, 2015 | USPTO record |
| US 6,544,556 | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor Lapsed on the fee record Ended Apr 8, 2015 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2015 | USPTO record |
| US 7,713,550 | Controlled release sodium valproate formulation Lapsed on the fee record Ended May 11, 2014 · USPTO record | Lapsed on the fee record | Ended May 11, 2014 | USPTO record |
| US 7,029,701 | Composition for the treatment and prevention of ischemic events Formerly held Lapsed on the fee record Ended Apr 18, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 18, 2014 | USPTO record |
| US 7,022,342 | Controlled release oral dosage form of beta-adrenergic blocking agents Formerly held Lapsed on the fee record Ended Apr 4, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2010 | USPTO record |